These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 1349823)

  • 1. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.
    Simhandl C; Meszaros K
    J Psychiatry Neurosci; 1992 Mar; 17(1):1-14. PubMed ID: 1349823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic principles for differential therapy of psychoses].
    Hell D; Bridler R
    Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic treatment of the psychotic symptoms in schizophrenia].
    Goldchluk A
    Vertex; 2002; 13 Suppl 1():4-11. PubMed ID: 12122421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithm for the treatment of acute psychotic episodes.
    Hayashida M; Nakane Y
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S3-7. PubMed ID: 10560890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
    McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
    J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All antipsychotics are equal, but some are more equal than others.
    Volavka J; Citrome L
    J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial.
    Emsley R; Niehaus DJ; Oosthuizen PP; Koen L; Ascott-Evans B; Chiliza B; van Rensburg SJ; Smit RM
    Psychiatry Res; 2008 Dec; 161(3):284-91. PubMed ID: 18962989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
    Zink M; Knopf U; Mase E; Kuwilsky A; Deuschle M
    Pharmacopsychiatry; 2006 May; 39(3):109-11. PubMed ID: 16721699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nosologic status of schizoaffective psychoses. Problems and empirical findings].
    Sauer H
    Nervenarzt; 1990 Jan; 61(1):3-15. PubMed ID: 2407967
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment guidelines for non-schizophrenic psychotic disorders?].
    Jäger M; Frasch K; Weinmann S; Becker T
    Psychiatr Prax; 2007 Nov; 34(8):370-6. PubMed ID: 17806003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.